Cite
HARVARD Citation
Sim, B. et al. (2023). Immunoglobulin replacement in hematological malignancies: a focus on evidence, alternatives, dosing strategy, and cessation rule. Leukemia & lymphoma. 64 (1), pp. 18-29. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Sim, B. et al. (2023). Immunoglobulin replacement in hematological malignancies: a focus on evidence, alternatives, dosing strategy, and cessation rule. Leukemia & lymphoma. 64 (1), pp. 18-29. [Online].